The consensus price target for Teradyne, Inc. (NASDAQ:TER) has increased by 4.8% over the past quarter, indicating analyst confidence.Despite high expectations, Goldman Sachs sets a conservative price target of $149, suggesting the current market valuation might be overly optimistic.Teradyne's strategic focus on semiconductor test equipment and AI-enabled robotics positions it for long-term growth, although its stock trades at a premium.Teradyne, Inc. (NASDAQ:TER) is a prominent player in the automatic test ...